deltatrials
Completed OBSERVATIONAL NCT02289924

Aflibercept (Eylea) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy (PERSEUS-IT)

PERSEUS-IT. A Prospective Non-intERventional Study to asSEss the Effectiveness of Aflibercept (Eylea®) in roUtine Clinical Practice in patientS With Wet Age-related Macular Degeneration in Italy

Sponsor: Bayer

Updated 24 times since 2017 Last updated: Nov 3, 2023 Started: Jan 9, 2015 Primary completion: Mar 28, 2019 Completion: Jul 8, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Wet Macular Degeneration and is currently completed. Bayer leads this study, which shows 24 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Sep 2017 · 3 months · monthly snapshot~Sep 2017 – ~Dec 2017 · 3 months · monthly snapshot~Dec 2017 – ~Apr 2018 · 4 months · monthly snapshot~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Aug 2018 · 31 days · monthly snapshot~Aug 2018 – ~Sep 2018 · 31 days · monthly snapshot~Sep 2018 – ~Oct 2018 · 30 days · monthly snapshot~Oct 2018 – ~Nov 2018 · 31 days · monthly snapshot~Nov 2018 – ~Dec 2018 · 30 days · monthly snapshot~Dec 2018 – ~Jan 2019 · 31 days · monthly snapshot~Jan 2019 – ~Feb 2019 · 31 days · monthly snapshot~Feb 2019 – ~Mar 2019 · 28 days · monthly snapshot~Mar 2019 – ~May 2019 · 2 months · monthly snapshot~May 2019 – ~Jun 2019 · 31 days · monthly snapshot~Jun 2019 – ~Jul 2019 · 30 days · monthly snapshot~Jul 2019 – ~Aug 2019 · 31 days · monthly snapshot~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshot~Jan 2021 – ~Dec 2023 · 35 months · monthly snapshot~Dec 2023 – ~Jul 2024 · 7 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 24 months · monthly snapshot

Change History

24 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Dec 2023 — Jul 2024 [monthly]

    Completed

  4. Jan 2021 — Dec 2023 [monthly]

    Completed

  5. Aug 2019 — Jan 2021 [monthly]

    Completed

    Status: Active Not RecruitingCompleted

Show 19 earlier versions
  1. Jul 2019 — Aug 2019 [monthly]

    Active Not Recruiting

  2. Jun 2019 — Jul 2019 [monthly]

    Active Not Recruiting

  3. May 2019 — Jun 2019 [monthly]

    Active Not Recruiting

  4. Mar 2019 — May 2019 [monthly]

    Active Not Recruiting

  5. Feb 2019 — Mar 2019 [monthly]

    Active Not Recruiting

  6. Jan 2019 — Feb 2019 [monthly]

    Active Not Recruiting

  7. Dec 2018 — Jan 2019 [monthly]

    Active Not Recruiting

  8. Nov 2018 — Dec 2018 [monthly]

    Active Not Recruiting

  9. Oct 2018 — Nov 2018 [monthly]

    Active Not Recruiting

  10. Sep 2018 — Oct 2018 [monthly]

    Active Not Recruiting

  11. Aug 2018 — Sep 2018 [monthly]

    Active Not Recruiting

  12. Jul 2018 — Aug 2018 [monthly]

    Active Not Recruiting

  13. Jun 2018 — Jul 2018 [monthly]

    Active Not Recruiting

  14. Apr 2018 — Jun 2018 [monthly]

    Active Not Recruiting

    Phase: NANone

  15. Dec 2017 — Apr 2018 [monthly]

    Active Not Recruiting NA

  16. Sep 2017 — Dec 2017 [monthly]

    Active Not Recruiting NA

  17. Jun 2017 — Sep 2017 [monthly]

    Active Not Recruiting NA

  18. Feb 2017 — Jun 2017 [monthly]

    Active Not Recruiting NA

    Status: RecruitingActive Not Recruiting · Phase: PHASE4NA

  19. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Jan 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Bayer
Data source: Bayer

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations